Cetuximab, as an EGFR inhibitor, can block the combination between EGFR and its ligands competitively, such as epidermal growth factor (EGF), resulting in inhibition of growth, invasion, and metastasis of tumor cells. The gene discussed is EGF; the disease is neoplasm.